170
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Clinically relevant thyroid disorders and inflammatory bowel disease are inversely related: a retrospective case-control study

ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 171-176 | Received 19 Sep 2020, Accepted 01 Dec 2020, Published online: 16 Dec 2020

References

  • Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–s106.
  • Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066–2078.
  • Peyrin-Biroulet L, Loftus EV, Jr, Colombel J‒F, et al. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts. Inflamm Bowel Dis. 2011;17:471–478.
  • Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99(7):1371–1385.
  • Morgan XC, Kabakchiev B, Waldron L, et al. Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. Genome Biol. 2015; 16:67
  • Reshef L, Kovacs A, Ofer A, et al. Pouch inflammation is associated with a decrease in specific bacterial taxa. Gastroenterology. 2015;149(3):718–727.
  • Eisenstein M. Biology: a slow-motion epidemic. Nature. 2016;540(7634):S98–S99.
  • Karmiris K, Avgerinos A, Tavernaraki A, et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. ECCOJC. 2016;10(4):429–436.
  • Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med. 2010;42(2):97–114.
  • Algaba A, Guerra I, Castaño A, al. Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease. World J Gastroenterol. 2013;19(48):9359–9365.
  • Kappelman MD, Farkas DK, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12(2):265–773.
  • Loftus EV, Jr, Tremaine WJ, Habermann TM, et al. Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol. 2000;95(9):2308–2312.
  • Jung YS, Han M, Park S, et al. Cancer risk in the early stages of inflammatory bowel disease in Korean patients: a nationwide population-based study. J Crohns Colitis. 2017;11(8):954–962.
  • Pooran N, Singh P, Bank S. Crohn's disease and risk of fracture: does thyroid disease play a role? World J Gastroenterol. 2003;9(3):615–618.
  • Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology. 2005;129(3):827–836.
  • Yakut M, Üstün Y, Kabacan G, et al. Thyroid disorders in patients with inflammatory bowel diseases. IJCM. 2011;02(02):89–92.
  • Casella G, De Marco E, Antonelli E, et al. The prevalence of hyper- and hypothyroidism in patients with ulcerative colitis. J Crohns Colitis. 2008;2(4):327–330.
  • Snook JA, de Silva HJ, Jewell DP. The association of autoimmune disorders with inflammatory bowel disease. Q J Med. 1989;72(269):835–840.
  • Levi Z, Fraser E, Krongrad R, et al. Factors associated with radiation exposure in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2009;30(11-12):1128–1136.
  • Fialho A, Fialho A, Kochhar G, et al. P-077 association of thyroid cancer with the use of biologics and immunomodulators in inflammatory bowel disease patients. Inflamm Bowel Dis. 2016;22:S33–S34.
  • Vagianos K, Bector S, McConnell J, et al. Nutrition assessment of patients with inflammatory bowel disease. J Parenter Enteral Nutr. 2007;31(4):311–319.
  • Wadhwa V, Lopez R, Shen B. Crohn's disease is associated with the risk for thyroid cancer. Inflamm Bowel Dis. 2016;22:2902‒2906.
  • Bianchi GP, Marchesini G, Gueli C, et al. Thyroid involvement in patients with active inflammatory bowel diseases. Ital J Gastroenterol. 1995;27(6):291–295.
  • Järnerot G, Azad Khan AK, Truelove SC. The thyroid in ulverative colitis and Crohn's disease. II. Thyroid enlargement and hyperthyroidism in ulcerative colitis. Acta Med Scand. 1975;197(1-2):83–87.
  • Martino E, Loviselli A, Velluzzi F, et al. Endemic goiter and thyroid function in central-southern Sardinia. Report on an extensive epidemiological survey. J Endocrinol Invest. 1994;17(8):653–657.
  • Loviselli A, Velluzzi F, Mossa P, et al. The Sardinian Autoimmunity Study: 3. studies on circulating antithyroid antibodies in Sardinian schoolchildren: relationship to goiter prevalence and thyroid function. Thyroid. 2001;11(9):849–857.
  • Dore MP, Rocchi C, Longo NP, et al. Effect of probiotic use on adverse events in adult patients with inflammatory bowel disease: a retrospective cohort study. Probiot Antimicro Prot. 2020;12(1):152–159.
  • Dore MP, Bilotta M, Malaty HM, et al. Diabetes mellitus and Helicobacter pylori infection. Nutrition. 2000;16(6):407–410.
  • Hammer B, Ashurst P, Naish J. Diseases associated with ulcerative colitis and Crohn’s disease. Gut. 1968;9(1):17–21.
  • Modebe O. Autoimmune thyroid disease with ulcerative colitis. Postgrad Med J. 1986;62(728):475–476.
  • Bonapace ES, Srinivasan R. Simultaneous occurrence of inflammatory bowel disease and thyroid disease. Am J Gastroenterol. 2001;96(6):1925–1926.
  • Ricart E, Panaccione R, Loftus EV, Jr, et al. Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study. Inflamm Bowel Dis. 2004;10(3):207–214.
  • Wilson JC, Furlano RI, Jick SS, et al. Inflammatory bowel disease and the risk of autoimmune diseases. J Crohns Colitis. 2016;10(2):186–193.
  • Bar Yehuda S, Axlerod R, Toker O, et al. The association of inflammatory bowel diseases with autoimmune disorders: a report from the epi-IIRN. J Crohns Colitis. 2019;13(3):324–329.
  • Biancone L, Armuzzi A, Scribano ML, et al. Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD study. Inflamm Bowel Dis. 2020;26:450–459.
  • Cao L. Assessment of thyroid cancer risk in more than 334,000 patients with inflammatory bowel disease: a case-control study and a meta-analysis. World J Surg Oncol. 2018;16(1):182.
  • Yano Y, Matsui T, Hirai F, et al. Cancer risk in Japanese Crohn's disease patients: investigation of the standardized incidence ratio. J Gastroenterol Hepatol. 2013;28(8):1300–1305.
  • Shizuma T. Concomitant thyroid disorders and inflammatory bowel disease: a literature review. Biomed Res Int. 2016;2016:5187061.
  • Delitala AP, Pilia MG, Ferreli L, et al. Prevalence of unknown thyroid disorders in a Sardinian cohort. Eur J Endocrinol. 2014;171(1):143–149.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.